DNMT3A and atherosclerosis: Thus, although it has recently been reported that the enhanced inflammation in loss of Dnmt3a in myeloid cells experimentally phenocopies the effect of loss of Tet2 in a mouse model of atherosclerosis,41 we cannot comment on potential combinatorial effects of LOY and TET2 CHIP‐driver mutations in patients with chronic heart failure.